Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.8K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Quantum Teleportation over Thermal Microwave Network.

Physical review letters·2026
Same author

From Triangular Correlated Paramagnet to Multi-q Noncoplanar Spin State in Spinel GeFe_{2}O_{4}.

Physical review letters·2026
Same author

Diagnostic Utility of Liver Biopsy in Persistent Unexplained Liver Enzyme Elevation: A Retrospective Cohort Study.

JGH open : an open access journal of gastroenterology and hepatology·2025
Same author

[Guide to the application of the 9th TNM classification for lung cancer : Statement/position paper of the Thoracic Pathology Working Group].

Pathologie (Heidelberg, Germany)·2025
Same author

Parity-dependent state transfer for direct entanglement generation.

Nature communications·2025
Same author

Label-free quantification of imaging features in the extracellular matrix of left and right-sided colon cancer tissues.

Scientific reports·2024
Same journal

[Connective (tissue) pathology: What brings us together!]

Der Pathologe·2022
Same journal

[Giant cell-containing tumors of bone and differential diagnoses].

Der Pathologe·2022
Same journal

[Automation and application of robotics in the pathology laboratory].

Der Pathologe·2022
Same journal

[Practical diagnostic aspects of uterine leiomyosarcoma in the context of the 2020 WHO classification].

Der Pathologe·2022
Same journal

[Artificial intelligence: a solution for the lack of pathologists?]

Der Pathologe·2022
Same journal

[Predictive immunocytochemistry in non-small cell lung carcinoma].

Der Pathologe·2022
See all related articles

Related Experiment Video

Updated: Mar 16, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K

[Thymic carcinomas].

P Ströbel1, C-A Weis2, A Marx2

  • 1Institut für Pathologie, Universitätsmedizin Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland. philipp.stroebel@med.uni-goettingen.de.

Der Pathologe
|August 20, 2016
PubMed
Summary
This summary is machine-generated.

Thymic carcinomas (TC) are rare but aggressive tumors. The new WHO classification aids pathologists in distinguishing TC from thymomas and other cancers, improving diagnosis and treatment.

Keywords:
Differential diagnosisImmunohistochemistryOncological strategiesThymomaWHO classification

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.7K
Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

12.8K

Related Experiment Videos

Last Updated: Mar 16, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

2.4K
An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.7K
Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice
17:59

Derivation of Thymic Lymphoma T-cell Lines from Atm-/- and p53-/- Mice

Published on: April 3, 2011

12.8K

Area of Science:

  • Oncology
  • Pathology

Background:

  • Thymic carcinomas (TC) are less common than thymomas but more aggressive and challenging to treat.
  • TC are more frequent in pediatric patients, where germ cell tumors are a key differential diagnosis.
  • Pathologists face challenges distinguishing TC from thymomas and metastatic tumors.

Purpose of the Study:

  • To highlight novel aspects of the WHO classification for thymic epithelial tumors.
  • To address diagnostic pitfalls in thymic carcinoma identification.
  • To improve the accuracy of TC diagnosis and subsequent patient management.

Main Methods:

  • Review of the latest WHO classification of thymic epithelial tumors.
  • Analysis of diagnostic challenges in differentiating TC from thymomas and other malignancies.
  • Discussion of therapeutically relevant diagnostic pitfalls.

Main Results:

  • The updated WHO classification provides refined criteria for diagnosing thymic carcinomas.
  • Key distinctions between TC and thymomas are clarified.
  • Strategies for differentiating TC from metastatic cancers are addressed.

Conclusions:

  • Accurate diagnosis of thymic carcinoma is crucial due to its aggressive nature.
  • The new WHO classification offers improved diagnostic tools for pathologists.
  • Addressing diagnostic pitfalls can lead to more effective treatment strategies for TC.